P2.03-34 the Relationship Between Treatment Response and Serum EGFR Level in Nonsmall Cell Lung Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1221
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.03-06 Serum Syndechan-1 Levels in Patients With Nonsmall Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Refining the Treatment of Advanced Nonsmall Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2010English

First-Line Treatment of EGFR-mutated Nonsmall Cell Lung Cancer: Critical Review on Study Methodology

European Respiratory Review
PulmonaryRespiratory Medicine
2014English

TP53 Mutations in Nonsmall Cell Lung Cancer

Journal of Biomedicine and Biotechnology
2011English

Inactivation ofLLC1 Gene in Nonsmall Cell Lung Cancer

International Journal of Cancer
Cancer ResearchOncology
2007English

Thyroid Metastasis From Nonsmall Cell Lung Cancer

Case Reports in Oncological Medicine
Oncology
2013English

Preoperative CYFRA 21-1 Level as a Prognostic Indicator in Resected Nonsmall Cell Lung Cancer

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1998English

Responses to Crizotinib Can Occur in C-Met Overexpressing Nonsmall Cell Lung Cancer After Developing EGFR-TKI Resistance

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

P2.03-01 Prevalence of EGFR Alterations in Chilean Lung Cancer Patients: A Retrospective Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy